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 Inflammation is associated with increased risk of prostate cancer. Diet can modulate 
inflammation through changes in energy and diet quality.  Diet quality scores, assessed by 
measuring what individuals eat, are related to inflammatory markers measured in the blood.  The 
purpose of this project is to measure diet quality using verified diet quality indices, and then to 
evaluate which of these indices scores is most closely associated with certain inflammatory 
biomarkers in overweight men with prostate cancer.   
Methods 
      Data was collected at three separate time points; baseline, surgery (after weight loss), 
and study end (after 12 weeks weight maintenance).  Two 24-hour recalls were entered into the 
Nutrition Data System for Research software and the dietary output was averaged and used, with 
authors’ guidance, to obtain scores for the Alternative Healthy Eating Index (AHEI), the Dietary 
Inflammatory Index (DII), and the energy-adjusted Dietary Inflammatory Index (e-DII).  Blood 
was centrifuged to obtain serum, which was then used to obtain high sensitivity C-Reactive 
Protein (hs-CRP), and Interleukin-6 (IL-6) measurements.  Inferential statistics were calculated 
to find associations between the dietary scores and the inflammatory biomarkers, hs-CRP and IL-
6.  
Results 
 At baseline the DII scores had the strongest correlation to IL-6 (R=0.0404), and none of 
the dietary scores correlated with hs-CRP in the appropriate direction.  When looking at changes 
from baseline to the surgery time-point, during weight loss, the e-DII scores had the strongest 
correlation to IL-6 (R=0.0554), and the AHEI scores had the strongest correlation to hs-CRP (R= 
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-0.258).  From the surgery time-point to the study end, during weight maintenance, the e-DII 
scores had the strongest correlation to IL-6 (R=0.3932), and the DII scores had the strongest 
correlation to hs-CRP (0.1741).  
Conclusion  
The associations in this study were weak, and several results were unanticipated.  Out of 
all three dietary scores, the e-DII was most strongly associated with IL-6, and the AHE was most 
strongly associated with hs-CRP.  It would be worthwhile to replicate these methods on a trial of 
a larger size and lower IL-6 detection range kit, and to see if these results would be replicated or 
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Chapter 1: Justification 
Chronic inflammation is an important mechanism in the development and progression of 
cancer.  Chronic inflammation causes tissue damage, releasing inflammatory cytokines, and as 
the tissue attempts to repair itself, DNA may become damaged, which may eventually lead to 
cancer development (1).  Furthermore, inflammatory cytokines have been identified as potential 
sources for  prostate cancer initiation and progression (2, 3).  As prostate cancer is the second 
most common cancer in men and the second leading cause of cancer death in non-smoking 
American men (4), modulating chronic inflammation through lifestyle modifications, such as 
dietary choices, may affect health outcomes for men with prostate cancer. 
 Excess body fat contributes to chronic inflammation.  Adipocytes secrete inflammatory 
cytokines, such as Interleukin-6 (IL-6) and C-reactive protein (CRP)(5), yet diet quality has also 
been shown to play a role in modulating inflammation.  As such, a patient’s diet may be a 
potential way to address and lower chronic inflammatory markers.  There are several tools that 
can yield a score related to diet quality and inflammation.  In this project we compare two of 
these indices, the Alternative healthy eating index (AHEI) and Dietary Inflammatory Index (DII) 
in order to evaluate which of these tools best correlates with inflammatory biomarkers in patients 
with prostate cancer. 
STATEMENT OF PURPOSE:  To investigate how the AHEI and DII relate to the inflammatory 
biomarkers IL-6 and high sensitivity C-reactive protein (hs-CRP) in overweight men with 
prostate cancer.  
Research Questions: 
1. Will the AHEI scores have a negative correlation to the IL-6 and hs-CRP values in 
overweight men with localized prostate cancer; will the DII scores have a positive 
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correlation with the IL-6 and hs-CRP values, and will the energy adjusted version of DII 
show a stronger positive relationship? 
2. Are changes in the AHEI score and/or the DII score associated with changes in 
circulating inflammatory biomarkers? 
3. Which diet score has a stronger correlation to the inflammatory biomarkers evaluated? 
Chapter 2: Review of the Literature 
Introduction and Background 
Tools that measure diet quality,  such as the AHEI and DII, have shown that dietary 
patterns are associated with inflammatory biomarkers.  A study by Fung et al. compared the 
accuracy of various dietary indices ability to evaluate inflammation by assessing each indexes 
relationship to inflammatory markers, including: CRP, IL-6, E-selectin, soluble intercellular cell 
adhesion molecule 1, and soluble vascular cell adhesion molecule 1 (6).  Fung compared the 
AHEI, the Healthy Eating Index (HEI), the Diet Quality Index Revised (DQI-R), the 
Recommended Foods Score (RFS), and the alternative Mediterranean Diet Index (aMED) scores 
of nurses from the Nurses’ Health Study cohort (n=660).  Fung reported that several dietary 
indices were associated with inflammatory biomarkers, but the AHEI was more strongly 
associated with these inflammatory biomarkers (6).  Unfortunately the DII was not included in 
this assessment.  Considering that the DII was created specifically to assess inflammation and 
given inflammation may be important to prevent cancer progression, a comparison between DII 
and AHEI is critically needed to improve our ability to assess dietary inflammation in patients 
with cancer. 
Prostate Cancer and Chronic Inflammation 
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 It is widely accepted that inflammation is associated with increased cancer risk (7).   
Chronic systemic inflammation, in particular, has been shown to be associated with increased 
risk of both the initiation of prostate cancer formation and with continued cancer growth (3).  
Circulating inflammatory biomarkers are typically used as surrogate markers for measuring 
chronic and systemic inflammation.  For example, CRP has been shown to be a significant 
predictor of prostate cancer survival (8).  In this study 98 men with prostate cancer were 
followed for 10 years with measurements on Gleason score and CRP.  CRP at high circulating 
levels was related to poorer survival rates in the prostate cancer patients (8).  Interleukin-6 is 
another inflammatory marker of interest, and is considered one of the best surrogate markers for 
chronic inflammation in regards to those with prostate cancer, according to a review by Nguyen 
et al. (9).  Higher levels of CRP and IL-6 are related to poorer outcomes in men with prostate 
cancer and greater carcinogenesis in the tissues (8, 10).  Given this existing evidence regarding 
the relationship of circulating CRP and IL-6 to prostate cancer pathogenesis and survival, these 
specific biomarkers will be used to assess the ability of dietary indices to evaluate inflammation 
in patients with prostate cancer.. 
Diet and Inflammation 
 Diet can modulate inflammation in the body.  Several studies, including randomized 
control trials (11, 12), have shown a relationship with dietary components and certain dietary 
patterns and their ability to modulate inflammation (13).  Other studies show relationships 
between diet and the risk of several chronic diseases (14, 15), including cancer (16, 17).  The 
influence of diet on inflammation may explain the attenuation of the risk for certain chronic 
diseases.  There are foods that exhibit anti-inflammatory effects such as fruits and vegetables, 
and food components such as omega-3 fatty acids, fiber and phytochemicals.  Likewise, there are 
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foods that have been shown to exhibit a pro-inflammatory effect as well.  Overall dietary patterns 
that increase the consumption of anti-inflammatory foods, while simultaneously decreasing the 
consumption of pro-inflammatory foods may be helpful for prostate cancer patients.  Capturing 
the overall net effect of diet quality is difficult to define and quantify, which is why tools like the 
AHEI and DII are useful. In the intervention from where we obtained this dataset, coaching was 
given to the participants, which emphasized that participants consume more non-starchy 
vegetables, plant-based protein such as soy, fruit, and starchy vegetables, while also reducing 
consumption of red meat, processed meats, and sugar-sweetened beverages (SSB). 
Evidence supports that increased intakes of fruits and vegetables can combat chronic 
inflammation (11), and non-starchy vegetable intake in particular may be most impactful (18).  
Increasing consumption of these beneficial foods is important but lowering consumption of 
refined carbohydrates and high glycemic foods may also lead to improvements in the 
inflammatory markers of interest (12).  A study by Watzl in 2005 (11) found that increased fruit 
and vegetable consumption appear to lower CRP plasma concentration.  In this randomized 
control trial (n=64), significant differences in CRP levels were observed when participants were 
given a low, medium, or high intake of fruits and vegetables, despite no differences in baseline 
measures.  The authors focused on both fruits and vegetables that were rich sources of 
carotenoids, dietary fiber, and phytochemicals, such as lycopene, which are considered beneficial 
for overall health (11).  A separate cross-sectional study found that women (n=486) who 
consumed higher amounts of fruits and vegetables had lower CRP and E-selectin serum levels, 
compared to those with diets higher in refined carbohydrates and saturated fat (18).  Refined 
carbohydrates offer little fiber and fewer vitamins, minerals, and phytonutrients compared to 
diets that replace them with fruits and vegetables.  Non-starchy vegetables, such as spinach and 
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cabbage, typically have a much lower glycemic index than their starchy vegetable counterparts, 
such as white potatoes.  Low-glycemic index diets typically contain larger amounts of non-
starchy vegetables and fewer starchy vegetables, refined carbohydrates, and sugar sweetened 
beverages have been shown to exhibit anti-inflammatory effects by lowering IL-6 and TNF-
alpha (12).  In one randomized control trial (n=28), participants exhibited much lower IL-6 levels 
after an intervention, which included a low-glycemic index diet plus exercise, and were 
compared to a high-glycemic index diet plus exercise (12).   
 Reducing red and processed meats and replacing those meat proteins with soy or plant 
protein is a dietary strategy that could potentially modulate chronic inflammation.   
Many cancers progress through inflammation, and the relationship between increased colon 
cancer risk and consumption of red and processed meats is well established (19).  The American 
Institute of Cancer Research recommends eating no more than 18 oz. of red meat per week (20).   
Red meat and processed meat are known to be carcinogenic with several proposed 
mechanisms (21).  Nitrates, nitrites, heme iron, and saturated fat are found in these food 
products, and have been shown to have mechanistic role in carcinogensis.  Red meat contains a 
nonhuman sialic acid, N-glycolylneuraminic acid (Neu5Gc), which is not found in poultry or 
fish.  It’s been proposed that Neu5Gc acts as an antigen in humans, and humans then create 
antibodies for this antigen, and this process has been illustrated in several mice models where 
Neu5Gc antibodies were shown to enhance tumor growth (22, 23).   
Processed meat may be from red mammalian meat or other meats, and they are defined 
by the method of preservation or processing, such as smoking, salting, curing, or adding a 
preservative such as nitrate to the meat.  These methods of processing and preservation may 
increase the risk of cancer and may increase inflammation.  The sodium content of processed 
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meats is significantly greater than their fresh meat counterparts, and sodium intake is associated 
with higher CRP levels in non-diabetic hypertensive patients (n=224) (24).  Schwedhelm, et al. 
found that red processed meats in comparison to unprocessed red meats, were borderline 
associated with increases in IL-6, but not significantly associated with CRP, despite the lack of 
statistically significant associations there was an observed positive correlation between the 
inflammatory biomarkers, which included CRP, IL-6, total TNF-alpha, sTNF-R1, and STNF-R2 
(25).  This evidence suggests further investigation into this area is needed.   
The association between both red and processed meat and inflammation, may be 
arbitrated by increasing body weight, despite this finding there continues to be an indication that 
intake of both red and processed meats is still associated with worsening health conditions (26).  
In contrast, increased intake of isoflavones, which are phytonutrients found in soy, are associated 
with lower inflammatory cytokines, including IL-6, in prostate cancer patients who were given a 
soy bread intervention in one clinical trial (27).  Soy foods contain unsaturated fats, along with 
the bioactive phytonutrients, such as isoflavones, which gives them a competitive advantage over 
the red and processed meats, in regards to the health of prostate cancer patients. 
 Sugar sweetened beverage (SSB) intake is known to contribute to weight gain and 
obesity (28).  Due to the relationship of increased adipocytes and how they increase 
inflammatory cytokines sugar sweetened beverages should be reduced or avoided.  Sugar 
sweetened beverages include drinks sweetened with fructose (i.e. juice), glucose, or high fructose 
corn syrup, and evidence from a crossover control randomized design study shows there is no 
difference between the type of sugar consumed and inflammation measured by CRP and IL-6 
(29).   
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 Increasing fruit and vegetable consumption, emphasizing plant protein and 
simultaneously reducing red meat, processed meats, and SSB may modulate chronic 
inflammation, and, coincidentally, align with the cancer survivorship guidelines from the 
American Cancer Institute (30).  The dietary indices, the AHEI and DII, which are used to 
measure diet quality and relate it to chronic disease risk, also align with these guidelines. 
The Alternative Healthy Eating Index 
 The AHEI is a tool that was developed to predict chronic disease risk, including using 
dietary intake analysis.  As previously reviewed, the AHEI has been favorably compared to other 
dietary indices – except the DII (6).  The AHEI was developed using nutrients and foods that are 
consistently related to chronic disease risk in the literature.  A score is yielded, and this score 
illuminates either a lower or increased chronic disease risk.  The scores range from 0 to 110, a 
higher score indicates a lower risk of chronic disease, while a lower score indicates a greater risk 
of chronic disease. 
 Typically, a food frequency questionnaire (FFQ) is given to participants, but other 
standardized methods of diet intake recording may be applied as well.  Output from the diet 
analysis software is used to create the AHEI score.  Servings of whole fruits and vegetables, 
whole grains, nuts, legumes, and of long chain omega-3 fatty acids (mg/day) will raise the score.  
Servings of SSB, juice, red meat, processed meat, trans fat (g/day), and sodium (mg/day) will 
lower the score.  Moderate consumption (1-2 servings) will raise the total score by 10, while no 
consumption of alcohol will raise the total score by 2.5, but consumption greater than what is 





The Dietary Inflammatory Index 
 The DII aims to quantify the inflammatory potential of the diet itself, and through this 
inflammatory potential the risk of chronic disease, including prostate cancer.  Prostate cancer 
risk was found to be associated with higher DII scores in a prospective cohort study (n=2771) 
(32), and similar associations between DII scores and prostate cancer risk were found in a 
separate case control design study (n=120) (33).   Evidence from a retrospective cohort study 
(n=726) shows that DII scores are also associated with survival in prostate cancer patients with 
more aggressive forms of prostate cancer (34).   
The DII was developed based on published data of foods and food components and their 
effects on various inflammatory biomarkers, including but not limited to the two of interest in 
this paper, C-reactive protein and IL-6 (35).  Through the literature review process, the 
investigators defined 45 different components of diet on which to base a score, but only 25 of 
which are needed to generate a score, therefore those who use this tool do not need to measure 
all 45 components in order to obtain a score (35).   
For our analysis we used 28 components or parameters for producing our scores: alcohol, 
vitamin B-12, vitamin B-6, beta-carotene, caffeine, total carbohydrate, cholesterol, total calories 
(energy), total fat, total dietary fiber, folate, iron, magnesium, mono-unsaturated fatty acids 
(MUFA), niacin, total protein, omega-3 fatty acids, poly-unsaturated fatty acids, selenium, 
riboflavin, saturated fat, thiamin, trans fat, vitamin A activity, vitamin C, vitamin D, vitamin E, 
and zinc.  Of these components some are pro-inflammatory such as trans-fat consumption, while 
others are anti-inflammatory such as poly-unsaturated fatty acid consumption.  Pro inflammatory 
food components will result in a higher score, while anti-inflammatory food components will 
lower the score.  Scores range from a minimum of -8.87 to a maximum of 7.98.  A higher score 
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using the DII is more associated with chronic disease risk, including cancer.  Conversely a lower 
score from the AHEI is more associated with disease risk.    
Excess Body Fat and Inflammation 
 There is a well-known link between obesity and cancer, as well as obesity and chronic 
inflammation.  Obesity is partially driven by a constant state of positive energy balance, where 
caloric intake exceeds energy expenditure.  A review by Hursting et al. notes that obesity is 
associated with greater levels of inflammatory cytokines including IL-6 and CRP in both humans 
and rat models (36).  This same review summarizes data showing the protective effect of caloric 
restriction for cancer prevention (36).  A single arm intervention study, where 20 obese women 
were placed on a caloric restricted formula type diet of 800 kcals for 28 days, found that the 
caloric restriction appeared to lower the serum inflammatory markers significantly, further 
supporting the role of energy intake in inflammation (37).   
 A modified version of the DII has been developed to adjust for the effects of energy 
intake when scoring inflammatory potential of the diet (38).  Scores from both the original DII 
and the energy-adjusted version (e-DII) will be explored to see if energy density will have a 
greater affect than the nutrients of the diet and which score performs better for predicting 
inflammation.  The e-DII is calculated by dividing each component by the total energy consumed 
in kilocalories and then multiplying by 1000 kilocalories. 
Chapter 3: Methods 
Study Design 
 Data for this project were collected from the Prostate Cancer: Guys Resilient by 
Individualized Training (Energy Balance for Prostate Cancer Survivorship) (PCaGRIT).  The 
PCaGRIT trial was a pilot study that aimed to test the feasibility of obtaining significant weight 
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loss in overweight men with prostate cancer using a comprehensive weight loss program prior to 
a prostatectomy surgery and weight maintenance post-operatively.  The weight management 
program used weekly behavioral face-to-face coaching sessions as well as self-monitoring using 
HIPAA compliant technology.  Weekly phone calls were also used for further coaching and 
accountability 
 Two, 24-hour dietary recalls were obtained at baseline, after weight loss and prior to a 
prostatectomy surgery, and after twelve weeks of weight maintenance.  These visits are referred 
to as baseline, surgery, and final study end.  Dietary recalls from a weekend and a weekday were 
entered into the NDSR database for analysis, and diet output data was then averaged from these 
two recalls.  The outputs from NDSR yielded the information on dietary components necessary 
to calculate the AHEI and DII scores.  The original indices were both developed using food 
frequency questionnaires (FFQ), and not 24-hour recalls.  The authors of the AHEI; Stephanie E. 
Chiuve and Teresa T. Fung were contacted to guide our approach for adapting scores from the 
24-hour recalls.  For scoring the DII and the energy adjusted DII (e-DII) the dataset of the 
averaged recalls was scored by the authors of the DII, Nitin Shivappa and James R Hebert.  
Twenty study subjects have dietary data, fifteen of which were in the experimental group, and 
five of which were controls.  From the intervention group, thirteen of the fifteen participants 
have data for all time points, one participant had data missing from the surgery time point, and 
two were missing the study end time point.  Of the five control subjects, four have data for the 
baseline time point, three have data for the prior to surgery time point as well as the post-surgery 
time point.  
 Blood samples were drawn at the baseline, surgery, and study end time points. The blood 
samples were centrifuged to obtain serum samples, which were then used to measure hs-CRP 
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and IL-6.  To measure the hs-CRP, 1 mL of serum from the blood sample was sent to Quest 
Diagnostics lab in Lenexa, KS and analyzed using nephelometry and a detection range of 0.2-
11.0mg/L.  Hs-CRP is the same as CRP, except that it is a more sensitive test and can detect 
lower levels of CRP than a typical CRP test.  All intervention participants had hs-CRP values at 
the baseline time point, fourteen of the fifteen intervention participants had hs-CRP values for 
the surgery time point, and thirteen had hs-CRP values for the study end post-surgery time point.  
All of the control participants had hs-CRP for baseline, while three of the five controls had hs-
CRP values for the surgery time point, and four of the five controls had hs-CRP values for the 
study end time point.  The MILLIPLEX MAP (Billerica, MA) human high sensitivity T cell 
magnetic bead panel assay (Cat. # HSTCMAG-28SK) was used to measure IL-6, and the sample 
plates were processed according to manufacturer’s instructions and read on Luminex 200 
instrument with xPONENT software.  The detection range for the IL-6 assay was 0.17 to 750 
pg/ml.  There were six time-points of IL-6 data from the intervention, and two time-points from 
the control, which were below the detection range for IL-6 of the sixty total time point samples 
for the study.  When the IL-6 value was below detection limits but above zero, a value of 0.085 
pg/ml was imputed to calculate for the disparity, and to ensure that these values were not 
assumed zero during analysis.  There were ten time-points of IL-6 data from the intervention, 
and six time-points of data from the control, which were not obtained due to not having a blood 
draw or having limited sample amounts for testing. 
Statistical Methods 
 Spearman correlations were calculated by statistician, Dr. Chalise, to find associations 
between the inflammatory markers and diet scores.  Dietary scores and inflammatory markers 
obtained at baseline were compared for associations.  Changes in values from baseline to the 
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surgery time point, during weight loss, were also compared for associations between the change 
in dietary score to changes in inflammatory markers.  From the surgery time point to the study 
end, the participants were in weight maintenance, and associations between changes in the 
dietary scores and the inflammatory markers were also compared in this time frame as well.   
Chapter 4: Results 
 The flow diagram in figure 1 was adapted from the poster for PCaGRIT, presented at the 
American Institute of Cancer Research conference in 2016.  Inferential statistics are described in 
the following tables.  Line graphs depicting all comparative associations are shown in figure 2. 







Refer to table 1 to see correlations between IL-6, hs-CRP and the dietary scores at 
baseline.  Positive associations between AHEI scores and both hs-CRP and IL-6, and a positive 
association between the DII score and IL-6 were detected.  The DII score was negatively 
associated with hs-CRP, and the e-DII score was negatively associated with both IL-6 and hs-
CRP.  The e-DII had stronger correlations with both IL-6 and hs-CRP compared to both the 
AHEI and the original DII. 
TABLE 1 BASELINE 










 During the weight loss phase of the trial, which took place between baseline and surgery 
time points, dietary scores changed over time.  The associations between the score changes and 
the IL-6 and hs-CRP inflammatory marker changes are summarized in table 2.  The AHEI score 
was positively associated with IL-6, but negatively associated with hs-CRP.  The DII score and 
e-DII scores were both positively associated with IL-6, and also both negatively associated with 
hs-CRP. 
TABLE 2 BASELINE TO SURGERY DURING WEIGHT LOSS 











 From the surgery time point to the final study time point, the participants were to 
maintain their weight for twelve weeks.  The associations between dietary scores and the 
inflammatory markers are located in table 3.  The AHEI scores were positively associated with 
IL-6, but negatively associated with hs-CRP.  The DII and e-DII scores were both positively 
associated with IL-6 and hs-CRP.  The AHEI score had the strongest association with IL-6, and 
the DII had the strongest association to hs-CRP. 
TABLE 3 SURGERY TO STUDY END DURING WEIGHT MAINTENANCE 










Chapter 5: Discussion and Conclusion 
Discussion 
The present study examined associations between dietary index scores and the 
inflammatory biomarkers, IL-6 and hs-CRP in overweight men with prostate cancer.  These 
associations were analyzed at baseline, from baseline to surgery (during weight loss), and from 
surgery to study end (during weight maintenance).  Among our cohort of patients with prostate 
cancer, the AHEI scores at baseline had a very weak positive relationship with IL-6 and hs-CRP, 
while the DII scores had a very weak positive relationship to IL-6, and a very weak negative 
relationship to hs-CRP.  Using the directionality of the associations as previously defined for 
each instrument, the DII was most strongly associated with IL-6 and the e-DII was most strongly 
associated with hs-CRP.  Stronger relationships were observed in this present study; however, 
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these stronger associations were inverse the anticipated association.  Looking at changes in 
dietary scores over time, during the weight loss phase of the trial, these data show that the e-DII 
scores were more strongly associated with IL-6 (0.0554, very weak), and the AHEI was more 
associated with hs-CRP (-0.258, weak).  During weight maintenance the e-DII score changes 
were most associated with changes in IL-6 (0.3932, weak), while the DII score changes were 
most associated with changes in hs-CRP (0.1741, very weak).  The majority of the reported 
associations are weak (<0.4). 
There were several unanticipated results.  These unanticipated findings include that the 
AHEI scores were positively associated to IL-6 and hs-CRP at baseline, instead of negatively 
associated as expected, given the higher AHEI scores relate to lower risks of chronic disease 
(40).  At baseline the DII was negatively correlated with hs-CRP, and the e-DII was negatively 
correlated with both hs-CRP and IL-6.  This is unexpected because higher scores in the DII are 
typically correlated with higher amounts of inflammation (35), yet these findings indicate the 
opposite.  During the weight loss phase, changes in the AHEI scores were positively associated 
with IL-6, while the DII and e-DII scores were both negatively associated with hs-CRP.  During 
the weight maintenance phase of the trial the AHEI scores were positively associated with IL-6.  
These findings counter findings by other researchers, and may be related to study limitations, 
which will be discussed further on.  
The AHEI was created as a way to measure the impact diet choices would make on the 
risk of developing chronic diseases, including cancer.  Several studies show that higher AHEI 
scores are inversely related to circulating levels of CRP and IL-6 (6, 41, 42).  In this sample 
AHEI scores held a weak positive association to hs-CRP at baseline, while changes in the scores 
showed a weak negative association.  The present study was a pilot trial, while the other studies 
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were epidemiological designs with much larger in sample sizes, and these differences in sample 
size may account for some of the differences observed in the findings.  Furthermore, the primary 
aims of epidemiologic studies are different than the aims of a weight loss intervention trial. Our 
population in PCaGRIT included only overweight men with prostate cancer while the 
comparable epidemilogical studies included disparate populations of adults with a wide range of 
health statuses.  The DII was purposefully created to measure dietary parameters which would 
affect inflammation (35).  DII scores have been shown to predict levels of CRP (n=1,054) (43) 
and IL-6 (n=11,053) (44).  In the present study the DII was negatively associated with hs-CRP at 
baseline and changes in the DII were negatively associated with changes in hs-CRP during the 
weight loss phase of the study as well.  This association is unexpected considering a higher DII 
score should relate to greater inflammatory potential, and thus hypothesized to be positively 
associated with hs-CRP.  Prior studies using the DII (43, 44) were done in an observational 
manner, and not a weight loss trial, and had much larger sample sizes than the present trial.  The 
e-DII was created to correct and adjust scores for energy intake, because energy intake may 
become a confounding variable in creating a score.  The e-DII scoring pattern is expected to 
behave similarly to the DII.  In the present study the findings show the e-DII negatively 
associated with IL-6 and hs-CRP at baseline, and negatively associated with hs-CRP during the 
weight loss phase of the trial.  These findings are surprising because the expected relationship is 
a positive association between the e-DII score and both of these inflammatory markers. 
There were several limitations to this analysis.  The trial was originally a pilot study 
looking at the feasibility of weight loss in overweight men with prostate cancer, and it was not 
designed to answer the aforementioned research questions regarding diet scores and their 
relationship to inflammatory markers.  The sample size was very limited, and of that sample not 
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all of the participants had data available for dietary analysis and some participants were missing 
measured inflammatory markers, and these limitations reduce statistical power.  Both of the 
AHEI and the DII were originally created to yield a score using food frequency questionnaires 
(FFQ), however, this analysis was done using 24-hour recalls.  The authors of both dietary 
indices guided the approach for scoring, but there are differences between these two methods.  
FFQ are representative of “habitual” intake over several months to a year period of time, but 
FFQ are not appropriate given the nature of a trial aimed at changing habitual intake over the 
course of the study.  24-hour recalls were more appropriate for this trial, but these recalls rely on 
the respondent’s memory and the skill of the interviewer to capture the most accurate 
information.  24-hour recalls can also give information on foods not commonly eaten, which is 
beneficial for a trial looking at changes over time,  such as PCaGRIT, but if the participant 
anticipated the recall and changed their eating habits, this may have resulted in an inaccurate 
picture of the participants daily eating habits and thus an inaccurate dietary score.  The DII has 
45 components in total that can be used to conceive a score, but our analysis only used 28 of 
these.  Despite assertions that a realizable score can be conceived with as few as 25 components, 
not using all 45 of the components may have impacted the realizable scores.  When running the 
blood serum samples to obtain IL-6, the first kit ran did not have a low enough detection range, 
and thus a large amount of data could not be acquired.  A kit with a lower detection range was 
found, and the samples were run again at a much later date.  IL-6 is known to degrade over time, 
and storage methods may impact the sample profile (45).  It is possible, given the storage time of 
the samples, that the IL-6 cytokines were affected, leading to inaccurate data. 
 Despite the limitations there were several strengths to this analysis.  The nature of the 
three separate time-points in the trial made it possible to observe change over time.  Two 24-hour 
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recalls were obtained, from a weekday and weekend day, and averaged to get a more accurate 
picture of habitual consumption.  Trained staff took the recalls.  The intervention participants in 
the trial also were able to lose 5-10% of their baseline body weight.  The WARRIOR study, 
which builds upon the PCaGRIT trial, but with a larger sample size, is now in progress, and may 
be able to further look into dietary index score changes and their relationship to circulating 
inflammatory biomarkers, as well as delineate more clearly, which diet index performs the best.  
In this new trial it may be possible to include more components of the DII, to yield more 
accurate scores, and use greater stringency with storage and measuring of IL-6, now that a lower 
detection range IL-6 kit has been described. 
Conclusion 
The associations in this study were weak, and several results were unanticipated.  Out of 
all three dietary scores, the e-DII was most strongly associated with IL-6, and the AHE was most 
strongly associated with hs-CRP.  It would be worthwhile to replicate these methods on a trial of 
a larger size and lower IL-6 detection range kit, and to see if these results would be replicated or 
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